These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33024189)

  • 1. Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.
    Al-Darraji A; Donahue RR; Tripathi H; Peng H; Levitan BM; Chelvarajan L; Haydar D; Gao E; Henson D; Gensel JC; Feola DJ; Venditto VJ; Abdel-Latif A
    Sci Rep; 2020 Oct; 10(1):16596. PubMed ID: 33024189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease.
    Al-Darraji A; Haydar D; Chelvarajan L; Tripathi H; Levitan B; Gao E; Venditto VJ; Gensel JC; Feola DJ; Abdel-Latif A
    PLoS One; 2018; 13(7):e0200474. PubMed ID: 30001416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury.
    Zhang B; Bailey WM; Kopper TJ; Orr MB; Feola DJ; Gensel JC
    J Neuroinflammation; 2015 Nov; 12():218. PubMed ID: 26597676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and Characterization of a Liposomal Azithromycin Formulation for Alternative Macrophage Activation.
    Masud AA; Alsharif FM; Creameans JW; Perdeh J; Feola DJ; Venditto VJ
    Front Drug Deliv; 2022; 2():. PubMed ID: 36407498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity.
    Zhang B; Kopper TJ; Liu X; Cui Z; Van Lanen SG; Gensel JC
    CNS Neurosci Ther; 2019 May; 25(5):591-600. PubMed ID: 30677254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A9 Links Inflammation and Repair in Myocardial Infarction.
    Marinković G; Koenis DS; de Camp L; Jablonowski R; Graber N; de Waard V; de Vries CJ; Goncalves I; Nilsson J; Jovinge S; Schiopu A
    Circ Res; 2020 Aug; 127(5):664-676. PubMed ID: 32434457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.
    Allijn IE; Czarny BMS; Wang X; Chong SY; Weiler M; da Silva AE; Metselaar JM; Lam CSP; Pastorin G; de Kleijn DPV; Storm G; Wang JW; Schiffelers RM
    J Control Release; 2017 Feb; 247():127-133. PubMed ID: 28065862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice.
    Toor IS; Rückerl D; Mair I; Thomson A; Rossi AG; Newby DE; Allen JE; Gray GA
    Clin Exp Immunol; 2019 Oct; 198(1):83-93. PubMed ID: 31119724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye.
    Ren T; Lin X; Zhang Q; You D; Liu X; Tao X; Gou J; Zhang Y; Yin T; He H; Tang X
    Mol Pharm; 2018 Nov; 15(11):4862-4871. PubMed ID: 30251864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation Mediated by Azithromycin in Experimental Periapical Inflammation.
    Andrada AC; Azuma MM; Furusho H; Hirai K; Xu S; White RR; Sasaki H
    J Endod; 2020 Nov; 46(11):1648-1654. PubMed ID: 32763436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses.
    Joelsson JP; Kricker JA; Arason AJ; Sigurdsson S; Valdimarsdottir B; Gardarsson FR; Page CP; Lehmann F; Gudjonsson T; Ingthorsson S
    Respir Res; 2020 Sep; 21(1):233. PubMed ID: 32912304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin has lung barrier protective effects in a cell model mimicking ventilator-induced lung injury.
    Joelsson JP; Myszor IT; Sigurdsson S; Lehmann F; Page CP; Gudmundsson GH; Gudjonsson T; Karason S
    ALTEX; 2020; 37(4):545-560. PubMed ID: 32449787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
    Du M; Yang W; Schmull S; Gu J; Xue S
    Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
    Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
    Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment.
    Gensel JC; Kopper TJ; Zhang B; Orr MB; Bailey WM
    Sci Rep; 2017 Jan; 7():40144. PubMed ID: 28057928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
    Yamashita Y; Nagaoka K; Kimura H; Suzuki M; Konno S; Fukumoto T; Akizawa K; Kaku N; Morinaga Y; Yanagihara K
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic Acid Oligosaccharides Improve Myocardial Function Reconstruction and Angiogenesis against Myocardial Infarction by Regulation of Macrophages.
    Wang N; Liu C; Wang X; He T; Li L; Liang X; Wang L; Song L; Wei Y; Wu Q; Gong C
    Theranostics; 2019; 9(7):1980-1992. PubMed ID: 31037151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin in-situ delivery with Pluronic F-127 hydrogel for myocardial infarction treatment: Enhancing efficacy and reducing hepatotoxicity.
    Yao Y; Shao F; Peng X; Wang H; Wang K; Zhu K
    Life Sci; 2024 Oct; 354():122963. PubMed ID: 39127316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.
    Li J; Shen D; Tang J; Wang Y; Wang B; Xiao Y; Cao C; Shi X; Liu HM; Zhao W; Zhang J
    Eur J Pharmacol; 2019 Jul; 854():307-319. PubMed ID: 31039343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
    de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
    Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.